Glioblastoma — Trials

Glioblastoma — Trials · CancerIndex

Clinical trials

Registered studies

1,750 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 486
Recruiting: 258
Ph III recruiting: 13
Growth YoY: +41%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (282)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02546102	Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma	suspended	Phase 3	234	Precision Life Sciences GroupINDUSTRY	3	Apr 3, 2024	clinicaltrials

Data updated 22 days agoSource updated Apr 3, 2024source: clinicaltrials